Literature DB >> 17608398

Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.

Ping Liu, Linus S Lin, Terence G Hamill, James P Jewell, Thomas J Lanza, Raymond E Gibson, Stephen M Krause, Christine Ryan, Waisi Eng, Sandra Sanabria, Xinchun Tong, Junying Wang, Dorothy A Levorse, Karen A Owens, Tung M Fong, Chun-Pyn Shen, Julie Lao, Sanjeev Kumar, Wenji Yin, Joseph F Payack, Shawn A Springfield, Richard Hargreaves, H Donald Burns, Mark T Goulet, William K Hagmann.   

Abstract

The discovery of a structurally distinct cannabinoid-1 receptor (CB1R) positron emission tomography tracer is described. Starting from an acyclic amide CB1R inverse agonist (1) as the lead compound, an efficient route to introduce 18F to the molecule was developed. Further optimization focused on reducing the lipophilicity and increasing the CB1R affinity. These efforts led to the identification of [18F]-16 that exhibited good brain uptake and an excellent signal-to-noise ratio in rhesus monkeys.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608398     DOI: 10.1021/jm070131b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.

Authors:  Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

2.  Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain.

Authors:  Sandra Marina Sanabria-Bohórquez; Terence G Hamill; Karolien Goffin; Inge De Lepeleire; Guy Bormans; H Donald Burns; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-24       Impact factor: 9.236

3.  Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.

Authors:  Sean R Donohue; Joseph H Krushinski; Victor W Pike; Eyassu Chernet; Lee Phebus; Amy K Chesterfield; Christian C Felder; Christer Halldin; John M Schaus
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

4.  Evaluation of cannabinoid type 1 receptor expression in the rat brain using [¹⁸F]MK-9470 microPET.

Authors:  I Miederer; S Maus; I Zwiener; G Podoprygorina; D Meshcheryakov; B Lutz; M Schreckenberger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-09       Impact factor: 9.236

5.  Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.

Authors:  Nashaat Turkman; Aleksander Shavrin; Vincenzo Paolillo; Hsin Hsien Yeh; Leo Flores; Suren Soghomonian; Brian Rabinovich; Andrei Volgin; Juri Gelovani; Mian Alauddin
Journal:  Nucl Med Biol       Date:  2012-01-04       Impact factor: 2.408

6.  Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.

Authors:  Sean R Donohue; Katarina Varnäs; Zhisheng Jia; Balázs Gulyás; Victor W Pike; Christer Halldin
Journal:  Bioorg Med Chem Lett       Date:  2009-09-03       Impact factor: 2.823

7.  PET imaging studies in rhesus monkey with the cannabinoid-1 (CB1) receptor ligand [11C]CB-119.

Authors:  Terence G Hamill; Linus S Lin; William Hagmann; Ping Liu; James Jewell; Sandra Sanabria; WaiSi Eng; Christine Ryan; Tung M Fong; Brett Connolly; Amy Vanko; Richard Hargreaves; Mark T Goulet; H Donald Burns
Journal:  Mol Imaging Biol       Date:  2009-01-07       Impact factor: 3.488

8.  Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.

Authors:  Sjoerd J Finnema; Sean R Donohue; Sami S Zoghbi; Amira K Brown; Balázs Gulyás; Robert B Innis; Christer Halldin; Victor W Pike
Journal:  Synapse       Date:  2009-01       Impact factor: 2.562

9.  Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.

Authors:  Sean R Donohue; Victor W Pike; Sjoerd J Finnema; Phong Truong; Jan Andersson; Balázs Gulyás; Christer Halldin
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

10.  18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.

Authors:  Kimy M Emonds; Michel Koole; Cindy Casteels; Laura Van den Bergh; Guy M Bormans; Filip Claus; Liesbeth De Wever; Evelyne Lerut; Hendrik Van Poppel; Steven Joniau; Herlinde Dumez; Karin Haustermans; Luc Mortelmans; Karolien Goffin; Koen Van Laere; Christophe M Deroose; Felix M Mottaghy
Journal:  EJNMMI Res       Date:  2013-08-02       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.